Physician profile
Leah D Webb
NPI 1689945644
$2,845.35
in general payments reported to CMS, 2019-2025
29 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $617 · 2022: $624 · 2023: $539 · 2024: $730 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $772.88 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $635.88 | 2021-2024 | |
| Biocryst US Sales Co., LLC | $337.86 | 2023-2025 | Orladeyo |
| Lilly USA, LLC | $218.76 | 2022-2024 | Mounjaro, Zepbound, Reyvow |
| Dexcom, INC. | $107.24 | 2024-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.09 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $69.55 | 2021 | |
| Sk Life Science, INC. | $63.46 | 2021 | |
| Amgen INC. | $49.27 | 2022 | |
| Eisai INC. | $48.07 | 2021 | |
| Sanofi-Aventis U.S. LLC | $45.64 | 2021-2023 | |
| Ultragenyx Pharmaceutical INC. | $42.08 | 2022-2023 | |
| Abbott Laboratories | $39.04 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Hologic Sales and Service, LLC | $35.81 | 2023 | Aptima |
| Pfizer INC. | $34.98 | 2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $33.35 | 2024 | Myrbetriq, Veozah |
| Radius Health, INC. | $26.99 | 2024 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $25.32 | 2024 | Rexulti |
| Baxter Healthcare | $20.32 | 2022 | |
| Merck Sharp & Dohme LLC | $18.93 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.63 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.72 | 2022 | |
| Vanda Pharmaceuticals INC. | $17.60 | 2024 | Fanapt |
| Bayer Healthcare Pharmaceuticals INC. | $17.28 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.99 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $15.45 | 2021 | |
| Tandem Diabetes Care, INC. | $14.39 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Irhythm Technologies, INC. | $12.96 | 2023 | Zio Xt Patch |
| Exact Sciences Corporation | $12.81 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.